Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data

Overview of attention for article published in Infection and Drug Resistance, March 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

wikipedia: 4 Wikipedia pages

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 66 Mendeley

Summary Wikipedia Dimensions citations

So far, Dimensions has found 42 publications that cite this research output.

42

The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.

Artemether–lumefantrine with or without single-dose primaquine and sulfadoxine–pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali

Article in The Lancet Microbe (May 2024)

Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2 single-blind randomised clinical trial in Ouelessebougou, Mali

Preprint in medRxiv (February 2024)

Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates

Article in Chemical Society Reviews (February 2024)